FLR
40
-8
MSFT
46
-7
FDX
37
-2
RF
60
-4
EMN
42
-3
IBM
50
-3
KLAC
53
-5
TMO
40
-3
ADSK
44
-5
PH
60
-7
GPC
47
-3
IFF
38
-3
AVGO
13
-2
FITB
55
-3
DE
53
-7
WDC
33
-4
DD
33
-4
GM
49
-3
SYK
37
-3
WMB
60
-2
FLR
40
-8
MSFT
46
-7
FDX
37
-2
RF
60
-4
EMN
42
-3
IBM
50
-3
KLAC
53
-5
TMO
40
-3
ADSK
44
-5
PH
60
-7
GPC
47
-3
IFF
38
-3
AVGO
13
-2
FITB
55
-3
DE
53
-7
WDC
33
-4
DD
33
-4
GM
49
-3
SYK
37
-3
WMB
60
-2
Financhill
Back

Cytokinetics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

CYTK
Cytokinetics

Last Price:
$43.21
Seasonality Move:
9.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 44.11 Sell
20-day SMA: 44.07 Sell
50-day SMA: 45.78 Sell
200-day SMA: 51.56 Sell
8-day EMA: 36.33 Buy
20-day EMA: 22.21 Buy
50-day EMA: 10.79 Buy
200-day EMA: 2.99 Buy

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.96 Buy
Relative Strength Index (14 RSI): 44.18 Sell
Chaikin Money Flow: 1258834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.81 - 47.07) Sell
Bollinger Bands (100): (44.51 - 51.81) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 43.19 while CYTK 8-day simple moving average is 44.11, which is a Sell signal.
  • The stock price of CYTK is 43.19 while Cytokinetics 20-day SMA is 44.07, which makes it a Sell.
  • Cytokinetics 50-day simple moving average is 45.78 while CYTK share price is 43.19, making it a Sell technically.
  • CYTK stock price is 43.19 and Cytokinetics 200-day simple moving average is 51.56, creating a Sell signal.

CYTK Technical Analysis vs Fundamental Analysis

Sell
23
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Sell
    The current Cytokinetics [CYTK] share price is $43.19. The Score for CYTK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.

Cytokinetics Stock Info

Market Cap:
5.1B
Price in USD:
43.19
Share Volume:
1.5M

Cytokinetics 52-Week Range

52-Week High:
75.71
52-Week Low:
40.53
Sell
23
Cytokinetics (CYTK) is a Sell

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 43.19 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 43.19 while CYTK 8-day exponential moving average is 36.33, which is a Buy signal.
  • The stock price of CYTK is 43.19 while Cytokinetics 20-day EMA is 22.21, which makes it a Buy.
  • Cytokinetics 50-day exponential moving average is 10.79 while CYTK share price is 43.19, making it a Buy technically.
  • CYTK stock price is 43.19 and Cytokinetics 200-day simple moving average is 2.99, creating a Buy signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.46 per share, and an increase next year of $0.81 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.